Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients

Gastroenterology

Volumn 146, Issue 5, 2014, Pages 1397-1407

  Gao, Qiang ^a   Zhao, Ying Jun ^b,c   Wang, Xiao Ying ^a   Guo, Wei Jie ^b   Gao, Song ^d   Wei, Lin ^b   Shi, Jie Yi ^a   Shi, Guo Ming ^a   Wang, Zhi Chao ^a   Zhang, Yuan Nv ^b   Shi, Ying Hong ^a   Ding, Jie ^b   Ding, Zhen Bin ^a   Ke, Ai Wu ^a   Dai, Zhi ^a   Wu, Fei Zhen ^e   Wang, Hui ^b   Qiu, Zhao Ping ^b   Chen, Zhi Ao ^b   Zhang, Zhen Feng ^b   Qiu, Shuang Jian ^a   Zhou, Jian ^a,c   He, Xiang Huo ^b,c   Fan, Jia ^a,c   more..

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^d SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^e FUDAN UNIVERSITY   (China)

Author keywords

Carcinogenesis; Keywords; Liver Cancer; Phosphorylation; Signal Transduction

Indexed keywords

NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 3; PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE;

ARTICLE; BILE DUCT CARCINOMA; CANCER RECURRENCE; CARCINOGENESIS; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; DNA SEQUENCE; EXOME; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SCREENING; SIGNAL TRANSDUCTION; SOMATIC MUTATION; TISSUE MICROARRAY; TUMOR GROWTH; TUMOR RECURRENCE;

CARCINOGENESIS; LIVER CANCER; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHOLANGIOCARCINOMA; DNA MUTATIONAL ANALYSIS; ENZYME ACTIVATION; EXOSOMES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PHENOTYPE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 3; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION;

EID: 84899032205     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.01.062     Document Type: Article

References (37)

1. A. Jemal, F. Bray, and M. Center et al. Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. S. Rizvi, and G.J. Gores Pathogenesis, diagnosis, and management of cholangiocarcinoma Gastroenterology 145 2013 1215 1229
3. D. Sia, V. Tovar, and A. Moeini et al. Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies Oncogene 32 2013 4861 4870
4. A.X. Zhu, and A.F. Hezel Development of molecularly targeted therapies in biliary tract cancers: reassessing the challenges and opportunities Hepatology 53 2011 695 704
5. C.K. Ong, C. Subimerb, and C. Pairojkul et al. Exome sequencing of liver fluke-associated cholangiocarcinoma Nat Genet 44 2012 690 693
6. W. Chan-On, M.L. Nairismagi, and C.K. Ong et al. Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers Nat Genet 45 2013 1474 1478
7. Y. Jiao, T.M. Pawlik, and R.A. Anders et al. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas Nat Genet 45 2013 1470 1473
8. G.L. Tyson, and H.B. El-Serag Risk factors for cholangiocarcinoma Hepatology 54 2011 173 184
9. F.M. Gu, Q. Gao, and G.M. Shi et al. Intratumoral IL-17(+) cells and neutrophils show strong prognostic significance in intrahepatic cholangiocarcinoma Ann Surg Oncol 19 2012 2506 2514
10. H. Liang, L.W. Cheung, and J. Li et al. Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer Genome Res 22 2012 2120 2129
11. K. Wang, J. Kan, and S.T. Yuen et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer Nat Genet 43 2011 1219 1223
12. C. Guichard, G. Amaddeo, and S. Imbeaud et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma Nat Genet 44 2012 694 698
13. C. Greenman, P. Stephens, and R. Smith et al. Patterns of somatic mutation in human cancer genomes Nature 446 2007 153 158
14. L. Pasqualucci, V. Trifonov, and G. Fabbri et al. Analysis of the coding genome of diffuse large B-cell lymphoma Nat Genet 43 2011 830 837
15. J. Huang, Q. Deng, and Q. Wang et al. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma Nat Genet 44 2012 1117 1121
16. S.A. Forbes, N. Bindal, and S. Bamford et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer Nucleic Acids Res 39 2011 D945 D950
17. Z. Diamantopoulou, P. Kitsou, and S. Menashi et al. Loss of receptor protein tyrosine phosphatase beta/zeta (RPTPbeta/zeta) promotes prostate cancer metastasis J Biol Chem 287 2012 40339 40349
18. M. Katoh Function and cancer genomics of FAT family genes (Review) Int J Oncol 41 2012 1913 1918
19. I. Martin-Kleiner, and K. Gall Troselj Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis Cancer Lett 289 2010 11 22
20. P.C. Ng, and S. Henikoff Accounting for human polymorphisms predicted to affect protein function Genome Res 12 2002 436 446
21. W. Huang da, B.T. Sherman, and R.A. Lempicki Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat Protoc 4 2009 44 57
22. S.G. Julien, N. Dube, and S. Hardy et al. Inside the human cancer tyrosine phosphatome Nat Rev Cancer 11 2011 35 49
23. K.A. Gray, L.C. Daugherty, and S.M. Gordon et al. Genenames.org: the HGNC resources in 2013 Nucleic Acids Res 41 2013 D545 D552
24. I.A. Adzhubei, S. Schmidt, and L. Peshkin et al. A method and server for predicting damaging missense mutations Nat Methods 7 2010 248 249
25. S.W. Hou, H.Y. Zhi, and N. Pohl et al. PTPH1 dephosphorylates and cooperates with p38gamma MAPK to increase ras oncogenesis through PDZ-mediated interaction Cancer Res 70 2010 2901 2910
26. H.Y. Zhi, S.W. Hou, and R.S. Li et al. PTPH1 cooperates with vitamin D receptor to stimulate breast cancer growth through their mutual stabilization Oncogene 30 2011 1706 1715
27. S. Hou, P.S. Suresh, and X. Qi et al. p38gamma Mitogen-activated protein kinase signals through phosphorylating its phosphatase PTPH1 in regulating ras protein oncogenesis and stress response J Biol Chem 287 2012 27895 27905
28. Y. Zheng, J. Schlondorff, and C.P. Blobel Evidence for regulation of the tumor necrosis factor alpha-convertase (TACE) by protein-tyrosine phosphatase PTPH1 J Biol Chem 277 2002 42463 42470
29. Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer Nature 487 2012 330 337
30. Z. Wang, D. Shen, and D.W. Parsons et al. Mutational analysis of the tyrosine phosphatome in colorectal cancers Science 304 2004 1164 1166
31. Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma Nature 474 2011 609 615
32. S.I. Nikolaev, D. Rimoldi, and C. Iseli et al. Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma Nat Genet 44 2011 133 139
33. D. Sia, Y. Hoshida, and A. Villanueva et al. Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes Gastroenterology 144 2013 829 840
34. J.B. Andersen, B. Spee, and B.R. Blechacz et al. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors Gastroenterology 142 2012 1021 1031.e15
35. Y. Xu, W. Xia, and D. Baker et al. Receptor-type protein tyrosine phosphatase beta (RPTP-beta) directly dephosphorylates and regulates hepatocyte growth factor receptor (HGFR/Met) function J Biol Chem 286 2011 15980 15988
36. L.G. Morris, B.S. Taylor, and T.G. Bivona et al. Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers Proc Natl Acad Sci U S A 108 2011 19024 19029
37. K. Wu, Z. Li, and S. Cai et al. EYA1 phosphatase function is essential to drive breast cancer cell proliferation through cyclin D1 Cancer Res 73 2013 4488 4499